Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses

Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses

Tigilanol tiglate is a novel small molecule approved as a veterinary pharmaceutical in Europe for intratumoural treatment of non-metastatic, non-resectable canine mast cell tumors. The drug has a “tumor agnostic” mode of action associated with induction of an acute inflammatory response at the treat...

Full description

Bibliographic Details
Main Authors: Thomas De Ridder, Mick Ruppin, Meagan Wheeless, Stephanie Williams, Paul Reddell
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Veterinary Science
Subjects:
equine
sarcoid
carcinoma
ocular
neoplasia
intratumoural
Online Access:https://www.frontiersin.org/article/10.3389/fvets.2020.00639/full

Similar Items

Similar Items